Enlivex Therapeutics Financials
| ENLV Stock | ILA 372.90 4.90 1.33% |
Enlivex |
Understanding current and past Enlivex Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Enlivex Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Enlivex Therapeutics' assets may result in an increase in income on the income statement.
Please note, the presentation of Enlivex Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Enlivex Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Enlivex Therapeutics' management manipulating its earnings.
Enlivex Therapeutics Stock Summary
Enlivex Therapeutics competes with Compugen, BioLine RX, Clal Biotechnology, and Evogene. Enlivex Therapeutics Ltd. operates as a clinical stage immunotherapy company. Enlivex Therapeutics Ltd. was incorporated in 2005 and is headquartered in Nes Ziona, Israel. ENLIVEX THERAPEUTI operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 50 people.| Foreign Associate | USA |
| Instrument | Israel Stock View All |
| Exchange | Tel Aviv Stock Exchange |
| ISIN | IL0011319527 |
| Business Address | 14 Einstein Street, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.enlivex.com |
| Phone | (972) 2 6208070 |
| Currency | ILA |
You should never invest in Enlivex Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Enlivex Stock, because this is throwing your money away. Analyzing the key information contained in Enlivex Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Enlivex Therapeutics Key Financial Ratios
Enlivex Therapeutics' financial ratios allow both analysts and investors to convert raw data from Enlivex Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Enlivex Therapeutics over time and compare it to other companies across industries.Enlivex Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Enlivex Therapeutics's current stock value. Our valuation model uses many indicators to compare Enlivex Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Enlivex Therapeutics competition to find correlations between indicators driving Enlivex Therapeutics's intrinsic value. More Info.Enlivex Therapeutics is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Enlivex Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Enlivex Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Enlivex Therapeutics Systematic Risk
Enlivex Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Enlivex Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Enlivex Therapeutics correlated with the market. If Beta is less than 0 Enlivex Therapeutics generally moves in the opposite direction as compared to the market. If Enlivex Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Enlivex Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Enlivex Therapeutics is generally in the same direction as the market. If Beta > 1 Enlivex Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Enlivex Therapeutics November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Enlivex Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Enlivex Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Enlivex Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Enlivex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Enlivex Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 25.31 | |||
| Value At Risk | (7.18) | |||
| Potential Upside | 6.84 |
Complementary Tools for Enlivex Stock analysis
When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |